PPHVanEck Pharmaceutical ETF
Grow my money#363 of 2944 for Grow my money
Seeks to replicate the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index.
VanEck · Since 2011 (14 years)
Annual Cost
0.36%
#1631 out of 5,332 ETFs
Fund Size
$1.3B
#873 out of 5,332 ETFs
Dividend Yield
1.76%
Track Record
14 years
#964 out of 5,332 ETFs
Performance
1 Year
+17.0%
3 Years
+11.5%
5 Years
+9.9%
What's inside
Asset class
Region
Focus
Pharmaceuticals
Asset allocation
Stocks
100.0%
Sector breakdown
Healthcare
100.0%
Top holdings
Eli Lilly and CoLLY18.5%
Novartis AG ADRNVS10.9%
Merck & Co IncMRK9.8%
Pfizer IncPFE5.3%
Novo Nordisk AS ADRNVO4.7%
Sanofi SA ADRSNY4.7%
Bristol-Myers Squibb CoBMY4.7%
GSK PLC ADRGSK4.6%
AstraZeneca PLCAZN.L4.4%
Johnson & JohnsonJNJ4.4%
Risk profile
Volatility (1Y)
18.2%
Moderate
Max drawdown
-29.7%
Worst peak-to-trough loss
Sharpe (3Y)
0.57
Decent risk-adjusted returns
Sortino (3Y)
0.82
Moderate downside risk
Similar ETFs
Data updated on 2026-05-05